# Module A Audit Report: Cross-Product Relational Coherence (46 Pairs)

```text
AUDIT SESSION HEADER
====================
Session ID        : 2026-08-25-Gemini-P27-Run3-ModuleA
Reviewing Model   : Gemini 3.7 Flash (gemini-3.7-flash)
Snapshot Commit   : 59664cacfe4cfbd43d212f84c5d164a09557c958
Producer Basis    : Part A: Gemini non-producer for both ends (claude_* × gpt_*); producer≠checker satisfied.
                    Part B: Provenance-ambiguous advisory pass (mixed ends; 8 mixed×gemini, 7 clean).
Total Pairs       : 46 (Part A: 31 pairs; Part B: 15 pairs)
Verdicts Summary  : CONTRADICTION: 0 | RECONCILABLE: 31 | NO_SHARED_DECISION: 15
Adjudication Role : Purely advisory for Luke's human adjudication.
```

## Executive Summary

Each of the 46 pairs in the Module A calibration package was evaluated against the core relational audit question:
> *Do these two items teach mutually contradictory rules, keys, thresholds, or safety actions for the same clinical decision, after testing the strongest real reconciliation?*

Across all 46 pairs:
- **Direct Contradictions (CONTRADICTION / DC):** 0 findings filed.
- **Reconcilable (RECONCILABLE / DISMISS):** 31 pairs. Apparent topical overlap resolves under valid clinical distinctions (e.g. drug class differences, patient acuity/severity stages, anatomical localization, clinical cue differentiation, or prevention vs emergency action).
- **No Shared Decision (NO_SHARED_DECISION / NULL-COHERENCE):** 15 pairs. Items were paired by surface formatting (e.g., dosage calculation math, ordered-response sequences, or general maternal/pediatric tags) but evaluate completely independent clinical decisions.
- **Jurisdictional Divergences / Source Checks:** 0 pairs required a source check (`sourceCheckNeeded: false` across all 46 records).

---

## Pair Summary Table

| # | Part | Item A ID | Item B ID | Shared Decision | Verdict | Confidence |
|---|---|---|---|---|---|---|
| 1 | A (1) | `claude_a_fib_amoxicillin_pediatric_15` | `fib_acetaminophen_tablets_027` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 2 | A (2) | `claude_a_fib_dopamine_drip_05` | `gpt_canonical_fib_heparin_rate_033` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 3 | A (3) | `claude_a_fib_dopamine_drip_05` | `gpt_pharm_easy_medium_2026_06_21_a_fib_heparin_rate_01` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 4 | A (4) | `claude_a_matrix_anticoagulant_monitoring_16` | `gpt_u6_matrix_cloze_2026_06_09_matrix_heparin_safety_11` | Clinical monitoring indications and safety managem... | `RECONCILABLE` | `HIGH` |
| 5 | A (5) | `claude_a_matrix_asthma_06` | `gpt_canonical_matrix_asthma_exacerbation_065` | Clinical assessment and severity categorization of... | `RECONCILABLE` | `HIGH` |
| 6 | A (6) | `claude_a_matrix_neonatal_assessment_46` | `gpt_canonical_matrix_newborn_findings_045` | Identification of normal transitional findings ver... | `RECONCILABLE` | `HIGH` |
| 7 | A (7) | `claude_a_matrix_wound_assessment_26` | `gpt_canonical_matrix_wound_assessment_077` | Clinical differentiation between normal surgical w... | `RECONCILABLE` | `HIGH` |
| 8 | A (8) | `claude_a_matrix_wound_assessment_26` | `gpt_u6_matrix_cloze_2026_06_09_matrix_post_thyroidectomy_complications_03` | Postoperative assessment and recognition of expect... | `RECONCILABLE` | `HIGH` |
| 9 | A (9) | `claude_a_matrix_wound_assessment_26` | `matrix_postop_findings_028` | Evaluation of expected recovery findings versus sy... | `RECONCILABLE` | `HIGH` |
| 10 | A (10) | `claude_a_mc_dabigatran_teaching_03` | `mc_warfarin_bleeding_teaching_018` | Client education regarding laboratory monitoring r... | `RECONCILABLE` | `HIGH` |
| 11 | A (11) | `claude_a_mc_metformin_contrast_13` | `gpt_deepen_2026_06_22_bow_10` | Periprocedural management and safety protocols for... | `RECONCILABLE` | `HIGH` |
| 12 | A (12) | `claude_a_mc_postpartum_fundus_41` | `gpt_canonical_cloze_postpartum_hemorrhage_044` | Immediate nursing assessment and stepwise interven... | `RECONCILABLE` | `HIGH` |
| 13 | A (13) | `claude_a_or_iv_push_safety_14` | `gpt_canonical_or_medication_error_084` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 14 | A (14) | `claude_a_or_iv_push_safety_14` | `gpt_canonical_or_telephone_order_110` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 15 | A (15) | `claude_a_or_iv_push_safety_14` | `or_hypoglycemia_actions_026` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 16 | A (16) | `claude_a_sata_eps_haloperidol_12` | `gpt_case_clozapine_toxicity_01_q2` | Identification and clinical interpretation of adve... | `RECONCILABLE` | `HIGH` |
| 17 | A (17) | `claude_a_sata_hf_discharge_02` | `gpt_case_gap_2026_06_11_community_resources_part_3_sata_actions` | Discharge planning, transitional care coordination... | `RECONCILABLE` | `HIGH` |
| 18 | A (18) | `claude_a_sata_hf_discharge_02` | `gpt_case_opus23_nat_toddler_01_q5` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 19 | A (19) | `claude_a_sata_hf_discharge_02` | `gpt_case_unsafe_premature_discharge_01_q4` | Nursing advocacy and safety evaluation regarding c... | `RECONCILABLE` | `HIGH` |
| 20 | A (20) | `claude_a_sata_hf_discharge_02` | `gpt_opus21_case_colostomy_lep_discharge_01_q2` | Assessment and verification of patient comprehensi... | `RECONCILABLE` | `HIGH` |
| 21 | A (21) | `claude_a_sata_hf_discharge_02` | `gpt_opus21_case_colostomy_lep_discharge_01_q6` | Post-discharge transitional care planning, home su... | `RECONCILABLE` | `HIGH` |
| 22 | A (22) | `claude_a_sata_mmr_vaccine_48` | `gpt_gap_2026_06_12_nonmcq_balanced_b_case_peds_dehydration_03_q5` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 23 | A (23) | `claude_a_sata_neonatal_jaundice_42` | `gpt_canonical_sata_breastfeeding_085` | Assessment and nursing management of neonatal nutr... | `RECONCILABLE` | `HIGH` |
| 24 | A (24) | `claude_a_sata_neonatal_jaundice_42` | `gpt_canonical_sata_pregnancy_warning_signs_053` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 25 | A (25) | `claude_a_sata_neonatal_jaundice_42` | `sata_newborn_safety_teaching_008` | Postpartum and newborn nursing care, parent educat... | `RECONCILABLE` | `HIGH` |
| 26 | A (26) | `claude_jun05_pharm_clozapine_teaching_05` | `gpt_case_clozapine_toxicity_01_q2` | Clinical recognition, patient education, and risk ... | `RECONCILABLE` | `HIGH` |
| 27 | A (27) | `claude_jun05_pharm_clozapine_teaching_05` | `gpt_case_clozapine_toxicity_01_q4` | Immediate nursing and medical intervention upon de... | `RECONCILABLE` | `HIGH` |
| 28 | A (28) | `claude_jun05_pharm_clozapine_teaching_05` | `gpt_case_clozapine_toxicity_01_q6` | Clinical monitoring, evaluation of recovery, and r... | `RECONCILABLE` | `HIGH` |
| 29 | A (29) | `claude_jun05_pharm_pca_opioid_safety_04` | `gpt_canonical_cloze_opioid_safety_094` | Recognition and emergency reversal of life-threate... | `RECONCILABLE` | `HIGH` |
| 30 | A (30) | `claude_moc_hipaa_breach_hl_b03` | `gpt_deepen_2026_06_22_moc_01` | Identification of protected health information (PH... | `RECONCILABLE` | `HIGH` |
| 31 | A (31) | `claude_moc_hipaa_breach_hl_b03` | `gpt_deepen_2026_06_22_moc_11` | Recognition of proper vs improper information tran... | `RECONCILABLE` | `HIGH` |
| 32 | B (1) | `cs_ckd_01_q3` | `gemini_jun05_a_sata_pacemaker_41` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 33 | B (2) | `cs_ckd_01_q3` | `trad_batchD_08` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 34 | B (3) | `cs_ckd_01_q3` | `trad_batchD_10` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 35 | B (4) | `cs_ckd_01_q3` | `trad_batchD_20` | Clinical assessment, dietary regulation, and nursi... | `RECONCILABLE` | `HIGH` |
| 36 | B (5) | `cs_ckd_01_q3` | `trad_batchD_24` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 37 | B (6) | `cs_ckd_01_q5` | `gemini_c8_08` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 38 | B (7) | `claude_a_sata_tracheostomy_09` | `cs_ckd_01_q3` | NONE | `NO_SHARED_DECISION` | `HIGH` |
| 39 | B (8) | `cs_stemi_vfib_04_part_1` | `gemini_b1_04` | Clinical assessment, electrocardiographic localiza... | `RECONCILABLE` | `HIGH` |
| 40 | B (9) | `claude_cs_jun06_pressure_injury_bcc_01` | `gpt_gap_2026_06_12_nonmcq_balanced_case_pressure_injury_nutrition_03` | Comprehensive nursing assessment, anatomical stagi... | `RECONCILABLE` | `HIGH` |
| 41 | B (10) | `claude_cs_jun06_pressure_injury_bcc_01_part_2` | `gpt_canonical_matrix_pressure_injury_040` | Core nursing interventions and safety precautions ... | `RECONCILABLE` | `HIGH` |
| 42 | B (11) | `claude_cs_jun06_pressure_injury_bcc_01_part_4` | `gemini_d8_10` | Clinical staging, anatomical classification, and d... | `RECONCILABLE` | `HIGH` |
| 43 | B (12) | `claude_cs_jun06_pressure_injury_bcc_01_part_4` | `opus_bcc_rehab_2026_06_10_01` | Pressure injury risk factor assessment (Braden Sca... | `RECONCILABLE` | `HIGH` |
| 44 | B (13) | `claude_cs_jun06_pressure_injury_bcc_01` | `gpt_case_gap_2026_06_11_case_pressure_injury_ltc_04` | Multimodal pressure injury management, clinical st... | `RECONCILABLE` | `HIGH` |
| 45 | B (14) | `claude_cs_jun06_pressure_injury_bcc_01` | `gpt_case_premium_2026_06_10_case04_pressure_injury_rehab` | Interdisciplinary pressure injury prevention, seat... | `RECONCILABLE` | `HIGH` |
| 46 | B (15) | `claude_cs_jun06_pressure_injury_bcc_01_part_2` | `gpt_case_gap_2026_06_11_pressure_ltc_part_2_sata_plan` | Core evidence-based nursing interventions for pres... | `RECONCILABLE` | `HIGH` |

---

## Detailed Pair Reviews

### Pair 1 (Part A #1)
- **Item A ID:** `claude_a_fib_amoxicillin_pediatric_15`
- **Item B ID:** `fib_acetaminophen_tablets_027`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Calculate pediatric weight-based oral suspension dose: 40 mg/kg/day divided q8h for 15 kg child with 250 mg/5 mL suspension equals 4 mL per dose (Daily: 40*15=600 mg; Per dose: 600/3=200 mg; Volume: 200*5/250=4 mL).
- **Keyed Rule A (ZH):** 计算儿科按体重口服混悬液剂量：15公斤儿童按40 mg/kg/天每8小时分次给药，使用250 mg/5 mL混悬液，每次给药4 mL（每日总剂量600 mg，每次200 mg，体积4 mL）。
- **Keyed Rule B (EN):** Calculate adult tablet dose: prescribed 650 mg PO with available 325 mg tablets equals 2 tablets (650 mg / 325 mg per tablet = 2 tablets).
- **Keyed Rule B (ZH):** 计算成人片剂剂量：医嘱650 mg口服，现有规格325 mg/片，应给予2片（650 mg / 325 mg = 2片）。
- **Strongest Real Reconciliation:** The two items evaluate completely independent mathematical dosage calculations for different medications (amoxicillin pediatric suspension vs acetaminophen oral tablets), different patient populations (15 kg pediatric vs adult unit dose), and different calculation algorithms.
- **Reconciliation Test:** Because neither item establishes a clinical decision rule or therapeutic threshold that constrains the other, there is no shared clinical decision space or contradictory guidance.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Format twin / calculation pairing flagged by Layer A similarity on dosage calculation mechanics; zero clinical rule conflict.

### Pair 2 (Part A #2)
- **Item A ID:** `claude_a_fib_dopamine_drip_05`
- **Item B ID:** `gpt_canonical_fib_heparin_rate_033`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Calculate weight-based IV inotrope infusion rate: dopamine 5 mcg/kg/min for 80 kg client with 400 mg in 250 mL D5W yields 15 mL/hr (Concentration 1,600 mcg/mL; dose 400 mcg/min; rate 0.25 mL/min * 60 = 15 mL/hr).
- **Keyed Rule A (ZH):** 计算按体重静脉正性肌力药输注速度：80公斤患者多巴胺5 mcg/kg/分，规格400 mg/250 mL D5W，输液泵设为15 mL/小时（浓度1,600 mcg/mL，剂量400 mcg/分，速度15 mL/小时）。
- **Keyed Rule B (EN):** Calculate continuous IV anticoagulant infusion rate: heparin 1,200 units/hr with 25,000 units in 500 mL D5W yields 24 mL/hr (Concentration 50 units/mL; 1,200 units/hr / 50 units/mL = 24 mL/hr).
- **Keyed Rule B (ZH):** 计算持续静脉抗凝药输注速度：肝素1,200单位/小时，规格25,000单位/500 mL D5W，输液泵设为24 mL/小时（浓度50单位/mL，速度24 mL/小时）。
- **Strongest Real Reconciliation:** Both items are independent IV pump infusion rate calculations involving different pharmacological classes (dopamine inotrope/vasopressor vs unfractionated heparin anticoagulant), distinct dosing metrics (mcg/kg/min vs units/hr), and unique bag concentrations.
- **Reconciliation Test:** No common clinical policy or dosing rule is shared; each calculation is mathematically and clinically independent.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Layer A format-twin pairing on IV infusion rate math; entirely independent clinical targets.

### Pair 3 (Part A #3)
- **Item A ID:** `claude_a_fib_dopamine_drip_05`
- **Item B ID:** `gpt_pharm_easy_medium_2026_06_21_a_fib_heparin_rate_01`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Calculate weight-based IV drip rate: dopamine 5 mcg/kg/min for 80 kg client with 400 mg in 250 mL D5W programs to 15 mL/hr.
- **Keyed Rule A (ZH):** 计算按体重静脉滴注速度：80公斤患者多巴胺5 mcg/kg/分，400 mg/250 mL D5W，输液泵设为15 mL/小时。
- **Keyed Rule B (EN):** Calculate IV heparin infusion pump rate: heparin 1,200 units/hr with 25,000 units in 250 mL D5W programs to 12 mL/hr (Concentration 100 units/mL; 1,200 / 100 = 12 mL/hr).
- **Keyed Rule B (ZH):** 计算静脉肝素输液泵速度：肝素1,200 units/hr，规格25,000 units/250 mL D5W，输液泵设为12 mL/hr（浓度100 units/mL，速度12 mL/hr）。
- **Strongest Real Reconciliation:** Item A tests dopamine weight-based calculation while Item B tests heparin units-per-hour calculation with a 250 mL bag concentration.
- **Reconciliation Test:** The two items share no clinical rule, threshold, or decision pathway; both present standalone dosage mathematics.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** No shared clinical decision; distinct drug regimens and concentrations.

### Pair 4 (Part A #4)
- **Item A ID:** `claude_a_matrix_anticoagulant_monitoring_16`
- **Item B ID:** `gpt_u6_matrix_cloze_2026_06_09_matrix_heparin_safety_11`
- **Shared Clinical Decision:** Clinical monitoring indications and safety management for clients receiving anticoagulant therapy, specifically unfractionated heparin (UFH).
- **Keyed Rule A (EN):** Unfractionated heparin infusions have unpredictable pharmacokinetics and require routine laboratory coagulation monitoring (aPTT or anti-Xa), whereas warfarin requires INR, and DOACs/standard prophylactic LMWH do not require routine coagulation monitoring.
- **Keyed Rule A (ZH):** 普通肝素输注药代动力学不可预测，需要常规实验室凝血监测（aPTT或抗Xa），华法林需监测INR，而DOAC及标准预防剂量LMWH无需常规凝血监测。
- **Keyed Rule B (EN):** In a client receiving continuous UFH for pulmonary embolism, a therapeutic aPTT and small stable puncture bruise permit continuing routine monitoring, whereas a platelet drop >50% (suspected HIT), new hematuria, or sudden severe headache with visual changes (suspected intracranial hemorrhage) require stopping the infusion and notifying the provider.
- **Keyed Rule B (ZH):** 在接受普通肝素治疗肺栓塞的患者中，治疗范围内的aPTT及穿刺点稳定小瘀斑可继续常规监测；但血小板下降>50%（疑似HIT）、新发血尿或突发剧烈头痛伴视力改变（疑似颅内出血）必须停用肝素并通知医生。
- **Strongest Real Reconciliation:** Item A establishes baseline class-level lab monitoring requirements across anticoagulants (establishing that continuous UFH requires aPTT/anti-Xa monitoring), while Item B tests acute bedside decision-making for specific clinical findings during active UFH infusion.
- **Reconciliation Test:** Both items agree that therapeutic aPTT monitoring is the standard baseline for UFH infusions, and both treat bleeding signs or thrombocytopenia as triggers for escalation rather than routine continuation.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Complementary matrix items: baseline lab monitoring requirement vs acute infusion safety action triggers.

### Pair 5 (Part A #5)
- **Item A ID:** `claude_a_matrix_asthma_06`
- **Item B ID:** `gpt_canonical_matrix_asthma_exacerbation_065`
- **Shared Clinical Decision:** Clinical assessment and severity categorization of physical findings in acute asthma exacerbations.
- **Keyed Rule A (EN):** Initial wheezing, SpO2 96% after 30 minutes, and mild tremor/tachycardia after albuterol are expected responses, whereas persistent tachypnea unresponsive to two bronchodilator treatments and inability to complete full sentences indicate severe exacerbation requiring immediate escalation.
- **Keyed Rule A (ZH):** 初始哮鸣音、治疗30分钟后SpO2 96%以及沙丁胺醇引起的轻度震颤/心动过速为预期表现；但经2次支气管扩张剂治疗后持续呼吸急促及无法说完整句子提示严重发作，需立即跟进。
- **Keyed Rule B (EN):** Wheezing, speaking in short phrases, and accessory muscle use are expected in moderate distress, whereas a silent chest, fatigue, drowsiness, and carbon dioxide retention signal ventilatory failure and impending arrest requiring emergency escalation.
- **Keyed Rule B (ZH):** 喘鸣、能说短句及使用辅助呼吸肌属于中度加重的预期表现；而胸部无声（静止胸）、嗜睡及二氧化碳潴留提示通气衰竭及呼吸骤停风险，需紧急跟进。
- **Strongest Real Reconciliation:** Both items reflect the standard clinical severity spectrum of acute asthma exacerbations: moderate exacerbation features active wheezing and speaking in phrases, while severe obstruction and ventilatory exhaustion manifest as inability to speak, silent chest, and lethargy.
- **Reconciliation Test:** The clinical cues and severity tiers match perfectly across both items; neither item contradicts the triage threshold or escalation triggers of the other.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent alignment across moderate vs severe/impending respiratory failure asthma indicators.

### Pair 6 (Part A #6)
- **Item A ID:** `claude_a_matrix_neonatal_assessment_46`
- **Item B ID:** `gpt_canonical_matrix_newborn_findings_045`
- **Shared Clinical Decision:** Identification of normal transitional findings versus pathologic cues requiring follow-up during neonatal assessment.
- **Keyed Rule A (EN):** In a 12-hour-old newborn, respiratory rate 52/min with mild irregularity, acrocyanosis in the first 24-48 hours, vaginal birth molding, and soft flat pulsating fontanelles are expected, while mottling with temperature 36.0 °C (96.8 °F) indicates cold stress requiring follow-up.
- **Keyed Rule A (ZH):** 出生12小时新生儿中，呼吸频率52次/分伴轻度不规则、生后24-48小时内肢端发绀、产道塑形及软平有搏动的前囟均为正常预期表现；而花斑皮肤伴体温36.0 °C提示冷应激，需跟进处理。
- **Keyed Rule B (EN):** In a newborn, peripheral acrocyanosis in the first day, quiet heart rate 130/min, and milia are expected normal findings, while nasal flaring, grunting (respiratory distress), and low temperature (cold stress) require prompt follow-up.
- **Keyed Rule B (ZH):** 新生儿外周手足发绀、安静时心率130次/分及粟粒疹为正常预期表现；鼻翼扇动、呻吟样呼吸（呼吸窘迫）及低体温（冷应激）需要及时跟进。
- **Strongest Real Reconciliation:** Both items teach identical neonatal assessment norms: acrocyanosis is benign and expected during early transition (first 24-48 hours), normal vitals include RR 30-60 and HR 110-160, while hypothermia/cold stress and respiratory distress signs require immediate nursing intervention.
- **Reconciliation Test:** There is zero discrepancy in vital sign thresholds, benign developmental findings, or abnormal trigger cues.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Complete concordance on neonatal transition physiology and cold stress/distress red flags.

### Pair 7 (Part A #7)
- **Item A ID:** `claude_a_matrix_wound_assessment_26`
- **Item B ID:** `gpt_canonical_matrix_wound_assessment_077`
- **Shared Clinical Decision:** Clinical differentiation between normal surgical wound healing and postoperative wound complications (infection, dehiscence).
- **Keyed Rule A (EN):** Small serous drainage, well-approximated edges, and mild early bruising (days 1-2) reflect normal primary intention healing, whereas purulent drainage with erythema/warmth (infection) and wound dehiscence with exposed tissue require provider follow-up.
- **Keyed Rule A (ZH):** 术后早期少量浆液性渗出、切口边缘对合良好及轻度瘀斑为正常一期愈合表现；脓性渗出伴红肿热（感染）及伤口裂开伴深层组织外露需通知医生跟进。
- **Keyed Rule B (EN):** Approximated edges with mild pinkness and small early serosanguineous drainage represent expected healing, whereas foul purulent drainage and increasing pain, warmth, and swelling indicate surgical site infection requiring follow-up.
- **Keyed Rule B (ZH):** 切口对合良好伴轻度粉红及术后早期少量浆液血性渗出为预期愈合；恶臭脓性渗出及进行性加重的疼痛、发热、肿胀提示手术部位感染，需跟进处理。
- **Strongest Real Reconciliation:** Both items evaluate early postoperative surgical incisions using identical wound assessment standards: scant serous/serosanguineous drainage and approximated margins are expected, whereas purulent exudate, spreading erythema/warmth, and dehiscence require nurse follow-up and provider notification.
- **Reconciliation Test:** The definitions of expected healing and infection/complication criteria are clinically identical and fully concordant.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Directly aligned post-op wound healing and infection triage criteria.

### Pair 8 (Part A #8)
- **Item A ID:** `claude_a_matrix_wound_assessment_26`
- **Item B ID:** `gpt_u6_matrix_cloze_2026_06_09_matrix_post_thyroidectomy_complications_03`
- **Shared Clinical Decision:** Postoperative assessment and recognition of expected surgical recovery signs versus acute surgical complications.
- **Keyed Rule A (EN):** In general postoperative wounds, small serous drainage and approximated edges represent normal healing, while purulent drainage and dehiscence require follow-up.
- **Keyed Rule A (ZH):** 一般外科切口中，少量浆液性渗出和边缘对合为预期愈合，脓性渗出和伤口裂开需跟进。
- **Keyed Rule B (EN):** At 6 hours post-thyroidectomy, mild sore throat and scant dry serosanguineous drainage are expected, whereas stridor/increased work of breathing (airway edema), perioral tingling/spasms (hypocalcemia from parathyroid damage), and neck swelling/tightness (expanding hematoma) are potential life-threatening complications requiring prompt emergency action.
- **Keyed Rule B (ZH):** 甲状腺切除术后6小时，轻微喉咙痛和敷料上少量干燥浆液血性渗液为预期表现；而喉鸣/呼吸困难（气道水肿）、口周麻木/抽搐（甲状旁腺损伤致低钙血症）及颈部肿胀/紧绷（活动性血肿）为危急并发症，需立即处理。
- **Strongest Real Reconciliation:** Item A addresses general cutaneous wound healing criteria, while Item B focuses on specialized post-thyroidectomy surgical complications (airway compromise, hematoma, hypoparathyroidism). Both agree that small non-expanding serosanguineous/serous drainage is expected early postoperatively.
- **Reconciliation Test:** General surgical wound principles and thyroidectomy-specific complication triggers operate in distinct, non-conflicting domains.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent relationship between general wound healing norms and thyroidectomy-specific emergency complications.

### Pair 9 (Part A #9)
- **Item A ID:** `claude_a_matrix_wound_assessment_26`
- **Item B ID:** `matrix_postop_findings_028`
- **Shared Clinical Decision:** Evaluation of expected recovery findings versus systemic and surgical complications in postoperative care.
- **Keyed Rule A (EN):** Small serous drainage, well-approximated edges, and mild early bruising are normal wound healing, whereas purulent drainage and dehiscence require follow-up.
- **Keyed Rule A (ZH):** 少量浆液性渗出、切口边缘对合良好及早期轻度瘀斑为正常愈合，脓性渗出及伤口裂开需跟进。
- **Keyed Rule B (EN):** In general postoperative assessment, moderate incisional pain on coughing and scant early serosanguineous drainage are expected, whereas urine output < 30 mL/hr (renal hypoperfusion) and unilateral calf pain/swelling (deep vein thrombosis) require follow-up.
- **Keyed Rule B (ZH):** 术后常规评估中，咳嗽时中度切口痛和早期少量浆液血性渗出属预期；尿量<30 mL/小时（肾灌注不足）及单侧小腿疼痛肿胀（深静脉血栓）需立即跟进。
- **Strongest Real Reconciliation:** Both items evaluate postoperative recovery findings: both classify scant serous/serosanguineous drainage as expected early post-op, while identifying localized complications (infection/dehiscence in Item A) and systemic complications (DVT/oliguria in Item B) as requiring prompt nursing follow-up.
- **Reconciliation Test:** The clinical classification of normal post-op healing versus complication indicators is completely consistent.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Consistent categorization of expected surgical recovery signs versus complications.

### Pair 10 (Part A #10)
- **Item A ID:** `claude_a_mc_dabigatran_teaching_03`
- **Item B ID:** `mc_warfarin_bleeding_teaching_018`
- **Shared Clinical Decision:** Client education regarding laboratory monitoring requirements and bleeding precautions across different oral anticoagulant classes.
- **Keyed Rule A (EN):** Dabigatran is a direct thrombin inhibitor (DOAC) with predictable pharmacokinetics that does NOT require routine INR monitoring (client statement claiming monthly INR is needed reflects a need for further teaching), while bleeding precautions and consulting provider before stopping are appropriate.
- **Keyed Rule A (ZH):** 达比加群是直接凝血酶抑制剂（DOAC），药代动力学可预测，不需要常规INR监测（患者声称每月查INR表明需要进一步指导），同时应采取出血预防并在停药前咨询医生。
- **Keyed Rule B (EN):** Warfarin is a vitamin K antagonist requiring bleeding precautions (e.g. electric razor, reporting unusual bleeding) and consistent dietary vitamin K intake (not complete elimination), and missed doses should never be doubled.
- **Keyed Rule B (ZH):** 华法林是维生素K拮抗剂，需要采取出血预防措施（如使用电动剃须刀、报告异常出血）并保持饮食中维生素K摄入稳定（而非完全避免），漏服绝不可加倍。
- **Strongest Real Reconciliation:** The two items teach distinct pharmacologic properties for two different anticoagulant classes: Warfarin requires regular INR monitoring and consistent vitamin K intake, whereas dabigatran (a DOAC) does not require routine INR monitoring. Both reinforce bleeding precautions.
- **Reconciliation Test:** The distinction between DOAC monitoring rules and warfarin monitoring rules is standard pharmacology; both items are entirely accurate and non-contradictory.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Accurate differentiation between DOAC (dabigatran) and vitamin K antagonist (warfarin) monitoring rules.

### Pair 11 (Part A #11)
- **Item A ID:** `claude_a_mc_metformin_contrast_13`
- **Item B ID:** `gpt_deepen_2026_06_22_bow_10`
- **Shared Clinical Decision:** Periprocedural management and safety protocols for metformin in clients receiving iodinated IV contrast media.
- **Keyed Rule A (EN):** Metformin is held prior to procedures using IV iodinated contrast and withheld for 48 hours afterward until renal function is confirmed stable, preventing contrast-induced nephropathy and subsequent lactic acidosis accumulation.
- **Keyed Rule A (ZH):** 使用含碘造影剂前应暂停二甲双胍，并在检查后暂停48小时直至复查确认肾功能稳定，以预防造影剂肾病及继发的乳酸酸中毒。
- **Keyed Rule B (EN):** Under contrast-exposure protocol, metformin is held on the day of iodinated contrast administration and restarted only after renal function (creatinine/eGFR) is reassessed and cleared by the provider, with blood glucose monitored during the hold.
- **Keyed Rule B (ZH):** 在含碘造影剂流程中，给造影剂当天暂停二甲双胍，且只有在重新评估肾功能（肌酐/eGFR）并经医生批准后方可恢复，停药期间需监测血糖。
- **Strongest Real Reconciliation:** Both items enforce the same standard patient safety principle: metformin must be withheld during iodinated contrast administration and cannot be resumed until post-procedure renal function has been evaluated to avoid the fatal risk of metformin-associated lactic acidosis.
- **Reconciliation Test:** The timing (holding around contrast exposure) and mandatory prerequisite for restarting (renal function reassessment) are fully concordant.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Complete clinical agreement on holding metformin and checking renal labs before restart.

### Pair 12 (Part A #12)
- **Item A ID:** `claude_a_mc_postpartum_fundus_41`
- **Item B ID:** `gpt_canonical_cloze_postpartum_hemorrhage_044`
- **Shared Clinical Decision:** Immediate nursing assessment and stepwise intervention for postpartum uterine atony and boggy fundus.
- **Keyed Rule A (EN):** When a postpartum fundus is boggy AND displaced laterally (specifically to the right of midline), bladder distension is the primary mechanical cause preventing contraction; assisting the client to void or catheterizing is the priority first intervention before fundal massage.
- **Keyed Rule A (ZH):** 当产后子宫底部松软且向中线右侧移位时，膀胱膨胀是阻碍子宫收缩的主要原因；协助患者排尿或导尿是优先于子宫按摩的首选干预措施。
- **Keyed Rule B (EN):** When a postpartum client exhibits active heavy bleeding (saturating a pad in 15 minutes) and the uterus is boggy and located midline above the umbilicus, immediate fundal massage is the priority action to stimulate myometrial contraction, followed by anticipated uterotonics (oxytocin).
- **Keyed Rule B (ZH):** 当产后患者出现活动性大出血（15分钟浸透产垫）且子宫底位于中线脐上松软时，立即进行子宫底部按摩是刺激子宫肌收缩的首选行动，随后预期使用缩宫素。
- **Strongest Real Reconciliation:** The priority intervention depends on the specific clinical cue: a laterally displaced boggy fundus (Item A) indicates urinary retention as the underlying cause requiring bladder decompression, whereas a midline boggy fundus with acute hemorrhage (Item B) indicates primary uterine atony requiring immediate bimanual fundal massage and uterotonic therapy.
- **Reconciliation Test:** These represent classic, distinct NCLEX decision pathways for postpartum fundal assessment; the physical examination cues (lateral displacement vs midline hemorrhage) dictate the appropriate first action without clinical contradiction.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Differentiated by anatomical cue: lateral displacement (empty bladder) vs midline heavy bleeding (fundal massage + oxytocin).

### Pair 13 (Part A #13)
- **Item A ID:** `claude_a_or_iv_push_safety_14`
- **Item B ID:** `gpt_canonical_or_medication_error_084`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Sequence for routine IV push medication administration: verify medication against order -> draw up/prepare medication -> verify patient identity -> administer at correct rate -> flush IV line.
- **Keyed Rule A (ZH):** 常规静脉推注给药顺序：核对医嘱与药物 -> 抽取/准备药物 -> 核对患者身份 -> 按正确速度推注 -> 冲洗静脉管路。
- **Keyed Rule B (EN):** Sequence of nurse actions upon discovering a medication administration error: assess client safety/vitals first -> notify provider and charge nurse -> implement ordered treatments/monitoring -> document clinical facts and complete incident report.
- **Keyed Rule B (ZH):** 发现给药错误后的护理行动顺序：首先评估患者安全/生命体征 -> 通知医生和责任护士 -> 执行医嘱治疗/监测 -> 记录客观事实并填写不良事件报告。
- **Strongest Real Reconciliation:** Item A teaches the procedural step-by-step technique for administering an IV push drug, whereas Item B teaches the clinical risk management workflow following an executed medication error.
- **Reconciliation Test:** The two items address different clinical scenarios and workflows; neither contains rules that contradict the other.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Format twin / ordered response pairing on general medication safety; entirely different procedural contexts.

### Pair 14 (Part A #14)
- **Item A ID:** `claude_a_or_iv_push_safety_14`
- **Item B ID:** `gpt_canonical_or_telephone_order_110`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Sequence for IV push medication administration: verify order -> draw up dose -> confirm patient identity -> administer at prescribed rate -> flush line.
- **Keyed Rule A (ZH):** 静脉推注给药步骤：核对医嘱 -> 准备剂量 -> 确认患者身份 -> 按速度推注 -> 冲管。
- **Keyed Rule B (EN):** Sequence for telephone order processing: write complete order down -> read back order to provider -> receive confirmation from provider -> document/transcribe order according to facility policy.
- **Keyed Rule B (ZH):** 电话医嘱处理步骤：记录完整医嘱 -> 向医生回读医嘱 -> 获得医生确认 -> 按机构制度记录/录入医嘱。
- **Strongest Real Reconciliation:** Item A details parenteral bedside drug administration steps, while Item B details verbal/telephone communication order entry and verification protocols.
- **Reconciliation Test:** Different procedural domains with zero shared decision overlap or conflicting rules.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Ordered response format pairing; completely distinct clinical safety procedures.

### Pair 15 (Part A #15)
- **Item A ID:** `claude_a_or_iv_push_safety_14`
- **Item B ID:** `or_hypoglycemia_actions_026`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Sequence for IV push administration: verify order -> prepare medication -> identify patient -> administer at rate -> flush line.
- **Keyed Rule A (ZH):** 静脉推注给药步骤：核对医嘱 -> 准备药物 -> 核对身份 -> 推注给药 -> 冲洗管路。
- **Keyed Rule B (EN):** Stepwise management of hypoglycemia in a conscious client: check blood glucose -> administer 15 g fast-acting carbohydrate -> recheck blood glucose in 15 minutes -> provide complex carbohydrate/protein snack once resolved -> notify provider if hypoglycemia persists.
- **Keyed Rule B (ZH):** 清醒患者低血糖分步处理：测血糖 -> 给15克速效碳水化合物 -> 15分钟后复测血糖 -> 缓解后进食复合碳水/蛋白质点心 -> 若持续低血糖通知医生。
- **Strongest Real Reconciliation:** Item A tests IV push procedural administration technique, while Item B tests the Rule of 15 emergency protocol for conscious hypoglycemia.
- **Reconciliation Test:** No common decision space exists between routine IV push administration and acute hypoglycemia management.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Ordered response format twin; completely separate clinical topics.

### Pair 16 (Part A #16)
- **Item A ID:** `claude_a_sata_eps_haloperidol_12`
- **Item B ID:** `gpt_case_clozapine_toxicity_01_q2`
- **Shared Clinical Decision:** Identification and clinical interpretation of adverse effects associated with psychotropic antipsychotic medications.
- **Keyed Rule A (EN):** First-generation antipsychotic haloperidol causes extrapyramidal side effects (EPS) due to D2 dopamine receptor antagonism, characterized by acute dystonia (torticollis), akathisia (motor restlessness), and pseudoparkinsonism (muscle rigidity, shuffling gait, masked facies).
- **Keyed Rule A (ZH):** 第一代抗精神病药氟哌啶醇通过阻断D2多巴胺受体引起锥体外系反应（EPS），表现为急性肌张力障碍（斜颈）、静坐不能（运动性不安）和假性帕金森综合征（肌肉僵硬、慌张步态、面具脸）。
- **Keyed Rule B (EN):** Second-generation atypical antipsychotic clozapine carries life-threatening risks of severe neutropenia/agranulocytosis (ANC < 1,000/µL with fever/sore throat) and acute drug-induced myocarditis (elevated troponin/BNP/CRP with S3, crackles, edema, tachycardia) requiring separate acute clinical pathways.
- **Keyed Rule B (ZH):** 第二代非典型抗精神病药氯氮平具有危及生命的严重中性粒细胞减少/粒细胞缺乏症（ANC<1,000/µL伴发热咽痛）和急性药物性心肌炎（肌钙蛋白/BNP/CRP升高伴S3、湿啰音、水肿、心动过速）风险，需独立急性处理路径。
- **Strongest Real Reconciliation:** Haloperidol (a typical FGA) and clozapine (an atypical SGA) belong to different chemical and pharmacological classes with distinct adverse effect profiles: typical agents have high EPS liability, whereas clozapine has low EPS liability but carries boxed warnings for agranulocytosis and myocarditis.
- **Reconciliation Test:** Both items accurately reflect drug-specific pharmacodynamics and toxicities without mutual contradiction.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent class-specific differentiation between FGA (haloperidol EPS) and SGA (clozapine hematologic/cardiac toxicity).

### Pair 17 (Part A #17)
- **Item A ID:** `claude_a_sata_hf_discharge_02`
- **Item B ID:** `gpt_case_gap_2026_06_11_community_resources_part_3_sata_actions`
- **Shared Clinical Decision:** Discharge planning, transitional care coordination, and client safety preparation prior to hospital discharge.
- **Keyed Rule A (EN):** Discharge teaching for a client with heart failure must instruct them to immediately report red-flag signs of acute fluid retention and decompensation (weight gain >= 2 lbs in 24 hours, orthopnea/extra pillows, resting HR > 100 bpm, worsening dependent edema unresponsive to elevation).
- **Keyed Rule A (ZH):** 心力衰竭患者出院宣教必须指导其立即报告急性液体潴留和失代偿的警示征象（24小时内体重增加>=2磅、端坐呼吸/加枕头、静息心率>100次/分、抬高下肢不缓解的加重水肿）。
- **Keyed Rule B (EN):** Discharge planning for a vulnerable client with complex social and resource barriers requires interprofessional collaboration (consulting case management/social work, confirming medication access/affordability, verifying home health eligibility, utilizing teach-back, and obtaining client consent).
- **Keyed Rule B (ZH):** 存在复杂社会与资源障碍的高危患者出院计划需要跨专业协作（咨询个案管理/社工、确认药物获取与支付能力、核实居家护理资格、使用回授法并获得患者同意）。
- **Strongest Real Reconciliation:** Item A covers disease-specific clinical self-monitoring instructions for heart failure, while Item B covers interdisciplinary resource coordination and health literacy strategies for discharge barrier resolution.
- **Reconciliation Test:** Clinical self-monitoring education and transitional social resource planning are complementary, non-conflicting components of comprehensive discharge planning.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Harmonious components of discharge planning: clinical self-care instructions vs social determinant barrier coordination.

### Pair 18 (Part A #18)
- **Item A ID:** `claude_a_sata_hf_discharge_02`
- **Item B ID:** `gpt_case_opus23_nat_toddler_01_q5`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Heart failure discharge education includes reporting acute fluid overload symptoms (2+ lb weight gain/day, orthopnea, tachycardia, worsening edema).
- **Keyed Rule A (ZH):** 心力衰竭出院指导包括报告急性体液过负荷症状（体重每日增加2磅以上、端坐呼吸、心动过速、水肿加重）。
- **Keyed Rule B (EN):** Discharge planning and psychosocial support for a toddler with suspected non-accidental trauma requires coordinating with social work and Child Protective Services (CPS), scheduling a follow-up skeletal survey in 2 weeks, providing non-judgmental support without promising CPS outcomes, and objectively documenting caregiver interactions.
- **Keyed Rule B (ZH):** 疑似非意外创伤（虐待）幼儿的出院计划与心理社会支持需要与社工和儿童保护服务机构（CPS）协调、预约2周后复查骨骼系统X线、提供非评判性支持（不擅自承诺CPS结果），并客观记录照护者陈述。
- **Strongest Real Reconciliation:** Item A addresses adult chronic disease self-monitoring education, while Item B addresses pediatric child maltreatment safety planning, forensic follow-up, and statutory CPS reporting.
- **Reconciliation Test:** Completely disjoint patient populations, clinical specialties, and legal/safety mandates; no shared decision exists.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Superficial pairing under discharge planning cluster; adult heart failure vs pediatric non-accidental trauma.

### Pair 19 (Part A #19)
- **Item A ID:** `claude_a_sata_hf_discharge_02`
- **Item B ID:** `gpt_case_unsafe_premature_discharge_01_q4`
- **Shared Clinical Decision:** Nursing advocacy and safety evaluation regarding client readiness for discharge and post-discharge self-care.
- **Keyed Rule A (EN):** Clients with heart failure require clear education on daily weights and early symptom escalation (weight gain >= 2 lbs/day, orthopnea, edema) to prevent acute decompensation.
- **Keyed Rule A (ZH):** 心衰患者需要明确掌握每日称重及早期症状上报（体重增加>=2磅/天、端坐呼吸、水肿）以防急性失代偿。
- **Keyed Rule B (EN):** When an unsafe, premature discharge is proposed for an unprepared client with unresolved medication access, cognitive, or functional barriers, the nurse must advocate for client safety by documenting concerns, refusing to expedite discharge solely for bed turnover, and mobilizing pharmacy, social work, case management, and home health support.
- **Keyed Rule B (ZH):** 当未做好准备且存在未解决用药、认知或功能障碍的患者面临不安全过早出院时，护士必须捍卫患者安全，记录担忧，拒绝仅为周转床位而仓促出院，并调动药房、社工、个案管理和居家护理支持。
- **Strongest Real Reconciliation:** Item A identifies the clinical self-management requirements for heart failure, while Item B establishes the ethical and professional duty of the nurse to halt discharge and assemble necessary support systems when a client lacks the capability or resources to safely execute self-management.
- **Reconciliation Test:** Patient education (Item A) and clinical advocacy against unsafe discharge (Item B) reinforce the same core goal of patient safety and preventable readmission reduction.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent pairing: clinical discharge teaching parameters vs nursing advocacy against unsafe premature discharge.

### Pair 20 (Part A #20)
- **Item A ID:** `claude_a_sata_hf_discharge_02`
- **Item B ID:** `gpt_opus21_case_colostomy_lep_discharge_01_q2`
- **Shared Clinical Decision:** Assessment and verification of patient comprehension and readiness during discharge education.
- **Keyed Rule A (EN):** Discharge teaching must emphasize reportable clinical cues of decompensation (weight gain >= 2 lbs/day, orthopnea, resting tachycardia, worsening edema).
- **Keyed Rule A (ZH):** 出院指导必须强调失代偿的可报告临床征象（体重日增>=2磅、端坐呼吸、静息心动过速、水肿加重）。
- **Keyed Rule B (EN):** Discharge readiness criteria for ostomy self-care in a limited English proficiency (LEP) client are NOT met when teaching was delivered without a certified medical interpreter, the client only gives brief non-concordant nods, the family member answers on behalf of the client, or the family assists during pouching demonstration rather than the client performing independent return demonstration.
- **Keyed Rule B (ZH):** 在英语受限（LEP）患者造口自护出院评估中，若未通过专业医疗口译宣教、患者仅有模糊附和、家属代答或家属协助演示而非患者独立回示，则视为尚未达到出院标准。
- **Strongest Real Reconciliation:** Item A addresses the substantive content of discharge education, while Item B establishes the rigorous procedural and communication criteria required to confirm that a patient genuinely understands and can independently perform necessary post-discharge care.
- **Reconciliation Test:** Substantive instruction and valid verification of comprehension/competence via language access are entirely harmonious.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent: self-management education content vs rigorous LEP discharge verification criteria.

### Pair 21 (Part A #21)
- **Item A ID:** `claude_a_sata_hf_discharge_02`
- **Item B ID:** `gpt_opus21_case_colostomy_lep_discharge_01_q6`
- **Shared Clinical Decision:** Post-discharge transitional care planning, home support, and multidisciplinary follow-up coordination.
- **Keyed Rule A (EN):** Heart failure discharge teaching equips the client to recognize and report acute cardiopulmonary deterioration.
- **Keyed Rule A (ZH):** 心力衰竭出院宣教使患者能够识别并报告急性心肺恶化征象。
- **Keyed Rule B (EN):** Post-discharge coordination for an LEP client newly living with an ostomy requires arranging home health nursing with language-concordant care or remote interpreter services, providing professionally translated written materials, scheduling ostomy clinic follow-up, and ensuring interpreter availability for telephone contacts.
- **Keyed Rule B (ZH):** 新造口LEP患者的出院后随访协调需要安排具备语言支持或远程口译的居家护理、提供专业翻译的书面材料、预约造口门诊随访，并确保电话联络时配备口译服务。
- **Strongest Real Reconciliation:** Item A focuses on clinical warning sign recognition, while Item B focuses on structural and linguistic transitional care coordination for post-surgical recovery at home.
- **Reconciliation Test:** Clinical red-flag education and language-concordant transitional care coordination operate in complete harmony.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Complementary aspects of safe transitional discharge planning.

### Pair 22 (Part A #22)
- **Item A ID:** `claude_a_sata_mmr_vaccine_48`
- **Item B ID:** `gpt_gap_2026_06_12_nonmcq_balanced_b_case_peds_dehydration_03_q5`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** MMR vaccine (live attenuated viral vaccine) is contraindicated in pregnancy (teratogenic risk), severe immunosuppression/advanced HIV, and prior anaphylaxis to gelatin/neomycin or MMR, but mild concurrent illness or low-grade fever is not a contraindication.
- **Keyed Rule A (ZH):** MMR疫苗（减毒活疫苗）禁用于孕妇（致畸风险）、严重免疫缺陷/晚期HIV以及既往对明胶/新霉素或MMR过敏者，但轻度急性疾病或低热不是禁忌证。
- **Keyed Rule B (EN):** Inpatient nursing care and infection control for a pediatric toddler with acute rotavirus gastroenteritis and severe dehydration requires Contact Precautions, strict intake/output recording, skin barrier protection for frequent diarrhea, and parent education on hand hygiene and oral rehydration.
- **Keyed Rule B (ZH):** 轮状病毒胃肠炎合并重度脱水幼儿的住院护理与感染控制要求采取接触隔离防护、严格记录出入量、使用皮肤屏障霜防红臀，并指导家长手卫生与口服补液。
- **Strongest Real Reconciliation:** Item A evaluates immunological contraindications for live vaccine administration in outpatient/preventative settings, whereas Item B evaluates acute inpatient bedside nursing care and contact isolation for active pediatric viral gastroenteritis.
- **Reconciliation Test:** These items share no common clinical decision, pharmacology, or infection protocol; live vaccine contraindications do not intersect with acute dehydration contact isolation.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Superficial pairing under isolation/pediatrics cluster; MMR immunizations vs acute gastroenteritis contact precautions.

### Pair 23 (Part A #23)
- **Item A ID:** `claude_a_sata_neonatal_jaundice_42`
- **Item B ID:** `gpt_canonical_sata_breastfeeding_085`
- **Shared Clinical Decision:** Assessment and nursing management of neonatal nutrition, hydration, and physiologic transition in the early newborn period.
- **Keyed Rule A (EN):** Neonatal jaundice appearing within the first 24 hours is pathologic and requires immediate evaluation; during phototherapy, the nurse must cover the infant's eyes and diaper area, maintain adequate hydration and frequent feeds to promote bilirubin clearance, and monitor serum bilirubin levels.
- **Keyed Rule A (ZH):** 出生24小时内出现的黄疸为病理性黄疸，需立即评估；光疗期间护士必须遮盖婴儿眼部和尿布区，保持充足水化和频繁喂养以促进胆红素排泄，并监测血清胆红素。
- **Keyed Rule B (EN):** Effective neonatal breastfeeding is evidenced by wide-open latch covering the areola, audible swallowing, frequent nursing (8-12 feedings per 24 hours), contentment between feeds, and age-appropriate wet and dirty diapers.
- **Keyed Rule B (ZH):** 有效母乳喂养的特征包括大张嘴含住乳晕、听到吞咽声、频繁哺乳（24小时内8-12次）、两次喂奶间表现满足以及达到日龄对应的排尿排便量。
- **Strongest Real Reconciliation:** Both items evaluate newborn physiological adaptation: frequent, effective breastfeeding (8-12 times daily as in Item B) stimulates bowel motility and meconium passage, which is a primary mechanism for preventing and treating neonatal hyperbilirubinemia managed under phototherapy (Item A).
- **Reconciliation Test:** The two items are clinically synergistic: breastfeeding adequacy and hydration directly support bilirubin clearance, with no contradictory recommendations.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Synergistic relationship between neonatal feeding adequacy and hyperbilirubinemia management.

### Pair 24 (Part A #24)
- **Item A ID:** `claude_a_sata_neonatal_jaundice_42`
- **Item B ID:** `gpt_canonical_sata_pregnancy_warning_signs_053`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Management of neonatal jaundice requires recognizing jaundice within 24 hours as pathologic and implementing phototherapy eye/genital protection and hydration.
- **Keyed Rule A (ZH):** 新生儿黄疸管理要求识别24小时内黄疸为病理性，并采取光疗眼部/会阴保护及补液。
- **Keyed Rule B (EN):** Antepartum obstetric warning signs requiring immediate provider notification include vaginal bleeding, severe headache with visual disturbances (preeclampsia), persistent epigastric pain, decreased fetal movement, and sudden rupture of membranes.
- **Keyed Rule B (ZH):** 产前需立即就医的产科警示体征包括阴道流血、剧烈头痛伴视力障碍（子痫前期）、持续上腹痛、胎动减少以及胎膜早破。
- **Strongest Real Reconciliation:** Item A evaluates newborn hyperbilirubinemia management, while Item B evaluates maternal antepartum obstetric warning signs for complications such as preeclampsia and placental abruption.
- **Reconciliation Test:** Completely separate patient populations (neonate vs pregnant mother) and clinical conditions with zero rule overlap.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Maternal-newborn general cluster pairing; zero shared decision space.

### Pair 25 (Part A #25)
- **Item A ID:** `claude_a_sata_neonatal_jaundice_42`
- **Item B ID:** `sata_newborn_safety_teaching_008`
- **Shared Clinical Decision:** Postpartum and newborn nursing care, parent education, and infant safety.
- **Keyed Rule A (EN):** Management of neonatal hyperbilirubinemia requires identifying early jaundice (<24 hr) as pathologic and protecting eyes and genitals while maintaining hydration during phototherapy.
- **Keyed Rule A (ZH):** 新生儿高胆红素血症管理要求识别早期黄疸（<24小时）为病理性，光疗时保护眼部与生殖器并维持水化。
- **Keyed Rule B (EN):** Newborn home safety discharge teaching requires placing the infant supine on a firm flat surface without loose bedding (safe sleep), installing a rear-facing car safety seat in the back seat, setting water heater temperature below 120 °F (49 °C), and proper bulb syringe suction technique (mouth before nose).
- **Keyed Rule B (ZH):** 新生儿居家安全出院指导要求将婴儿仰卧置于平坦硬床面且无松散床品（安全睡眠）、在后排安装后向式安全座椅、热水器温度设在120 °F（49 °C）以下，以及正确的吸球使用方法（先口后鼻）。
- **Strongest Real Reconciliation:** Item A addresses inpatient clinical phototherapy safety and jaundice assessment, while Item B addresses post-discharge environmental and physical safety guidance for parents. Both represent core components of maternal-newborn nursing care.
- **Reconciliation Test:** Clinical phototherapy guidelines and household newborn safety guidelines operate in distinct, complementary spheres of newborn care.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent newborn care: inpatient phototherapy management vs outpatient infant safety education.

### Pair 26 (Part A #26)
- **Item A ID:** `claude_jun05_pharm_clozapine_teaching_05`
- **Item B ID:** `gpt_case_clozapine_toxicity_01_q2`
- **Shared Clinical Decision:** Clinical recognition, patient education, and risk interpretation of life-threatening adverse effects of clozapine.
- **Keyed Rule A (EN):** Clozapine patient education requires instructing the client to immediately report infection signs (sore throat, fever) due to agranulocytosis risk, keep all appointments for scheduled ANC blood tests throughout therapy, report constipation (gastrointestinal hypomotility risk), change positions slowly (orthostatic hypotension), and never discontinue therapy abruptly.
- **Keyed Rule A (ZH):** 氯氮平用药教育要求指导患者因粒细胞缺乏风险立即报告感染征象（咽痛、发热）、在整个治疗期按时完成定期的ANC血液检查、报告便秘（胃肠动力低下风险）、缓慢改变体位（直立性低血压），且绝不可自行骤停药物。
- **Keyed Rule B (EN):** In a hospitalized client taking clozapine who develops fever, sore throat, ANC 980/µL, elevated cardiac enzymes (troponin/CRP), S3, crackles, and peripheral edema, the nurse must interpret these findings as concurrent acute febrile neutropenia and clozapine-induced myocarditis requiring separate emergency treatment pathways.
- **Keyed Rule B (ZH):** 在服用氯氮平并出现发热、咽痛、ANC 980/µL、心肌酶升高（肌钙蛋白/CRP）、S3、湿啰音及外周水肿的住院患者中，护士必须将其识别为同时发生的急性发热性中性粒细胞减少和氯氮平诱导的心肌炎，需分别采取急症处理。
- **Strongest Real Reconciliation:** Item A provides preventative client education on warning signs (fever/sore throat indicating neutropenia), while Item B tests diagnostic recognition when a client actually manifests those exact clinical toxicities (fever + ANC < 1,000 + myocarditis).
- **Reconciliation Test:** The educational warning cues taught to the patient in Item A directly correspond to the pathological toxicity indicators identified in Item B.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Complete concordance between clozapine patient warning signs and clinical toxicity identification.

### Pair 27 (Part A #27)
- **Item A ID:** `claude_jun05_pharm_clozapine_teaching_05`
- **Item B ID:** `gpt_case_clozapine_toxicity_01_q4`
- **Shared Clinical Decision:** Immediate nursing and medical intervention upon detecting acute clozapine toxicity.
- **Keyed Rule A (EN):** Clients on clozapine must be taught that fever and sore throat represent urgent potential agranulocytosis requiring immediate medical evaluation.
- **Keyed Rule A (ZH):** 使用氯氮平的患者必须接受宣教，明确发热和咽痛代表需立即就医评估的潜在粒细胞缺乏症。
- **Keyed Rule B (EN):** When clozapine-induced febrile neutropenia and suspected myocarditis are detected, immediate nursing actions include: holding clozapine immediately, initiating neutropenic precautions, drawing blood cultures prior to broad-spectrum antibiotics, starting continuous cardiac telemetry, and consulting cardiology and hematology.
- **Keyed Rule B (ZH):** 当发现氯氮平引起的发热性中性粒细胞减少及疑似心肌炎时，立即采取的护理措施包括：立即停用氯氮平、启动中性粒细胞减少保护性隔离、在使用广谱抗生素前抽取血培养、开启持续心电监护，并紧急请心内科与血液科会诊。
- **Strongest Real Reconciliation:** Item A instructs the client to report the red-flag symptoms immediately, while Item B details the inpatient acute clinical response protocol triggered when those exact symptoms and lab abnormalities are reported.
- **Reconciliation Test:** The clinical escalation protocol in Item B perfectly operationalizes the safety rationale taught to the patient in Item A.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Direct alignment: patient warning education vs hospital emergency management protocol for clozapine toxicity.

### Pair 28 (Part A #28)
- **Item A ID:** `claude_jun05_pharm_clozapine_teaching_05`
- **Item B ID:** `gpt_case_clozapine_toxicity_01_q6`
- **Shared Clinical Decision:** Clinical monitoring, evaluation of recovery, and rechallenge safety following clozapine toxicity.
- **Keyed Rule A (EN):** Clozapine requires ongoing absolute neutrophil count (ANC) monitoring throughout the entire duration of therapy, as hematologic toxicity can occur at any time.
- **Keyed Rule A (ZH):** 氯氮平在整个治疗期间均需要持续监测中性粒细胞绝对计数（ANC），因为血液学毒性可在任何阶段发生。
- **Keyed Rule B (EN):** Following clozapine discontinuation for acute toxicity, recovery must be evaluated by objective serial trends (rising ANC, falling troponin/CRP, echocardiographic improvement); minor vital sign stabilization does not indicate resolution, clozapine must NOT be restarted, and worsening perfusion/infection requires immediate escalation.
- **Keyed Rule B (ZH):** 因急性毒性停用氯氮平后，必须通过客观连续指标评估恢复（ANC回升、肌钙蛋白/CRP下降、超声心动图改善）；轻微生命体征稳定不等于毒性消退，绝不能重启氯氮平，出现灌注或感染恶化需立即升级处理。
- **Strongest Real Reconciliation:** Both items emphasize objective biomarker monitoring (ANC trends) rather than subjective clinical impression, and both treat clozapine toxicity as a high-stakes clinical event where medication cessation and continued surveillance are mandatory.
- **Reconciliation Test:** Both items reinforce the necessity of ongoing laboratory surveillance and strict avoidance of unauthorized clozapine resumption.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent alignment on laboratory-driven monitoring and safety rules for clozapine.

### Pair 29 (Part A #29)
- **Item A ID:** `claude_jun05_pharm_pca_opioid_safety_04`
- **Item B ID:** `gpt_canonical_cloze_opioid_safety_094`
- **Shared Clinical Decision:** Recognition and emergency reversal of life-threatening opioid-induced respiratory depression.
- **Keyed Rule A (EN):** A client receiving IV PCA morphine who becomes unarousable with severe bradypnea (RR 6/min) and hypoxemia (SpO2 84%) is experiencing severe opioid overdose requiring immediate administration of the opioid antagonist naloxone IV.
- **Keyed Rule A (ZH):** 接受静脉PCA吗啡的患者出现无法唤醒、严重呼吸过缓（RR 6次/分）和低氧血症（SpO2 84%）时，属于严重阿片类药物过量，需要立即静脉给予阿片受体拮抗剂纳洛酮。
- **Keyed Rule B (EN):** A postoperative client who is difficult to arouse with RR 8/min, SpO2 88%, and pinpoint pupils is exhibiting opioid-induced respiratory depression, requiring airway/respiratory support and naloxone administration per protocol/prescription.
- **Keyed Rule B (ZH):** 术后患者难以唤醒伴呼吸8次/分、SpO2 88%及针尖样瞳孔，表现为阿片类药物引起的呼吸抑制，需要按流程或医嘱提供气道/呼吸支持并给予纳洛酮。
- **Strongest Real Reconciliation:** Both items present the classic clinical triad of opioid toxicity (central nervous system depression / sedation, bradypnea < 8-10/min, hypoxemia / pinpoint pupils) and mandate the identical immediate nursing intervention: supporting airway/breathing and administering naloxone to reverse respiratory depression.
- **Reconciliation Test:** The clinical recognition criteria and emergency pharmacologic antidote (naloxone) are identical across both items.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Complete concordance on opioid toxicity recognition and emergency naloxone administration.

### Pair 30 (Part A #30)
- **Item A ID:** `claude_moc_hipaa_breach_hl_b03`
- **Item B ID:** `gpt_deepen_2026_06_22_moc_01`
- **Shared Clinical Decision:** Identification of protected health information (PHI) confidentiality breaches versus permitted disclosures under HIPAA Privacy Rule standards.
- **Keyed Rule A (EN):** Breaches of confidentiality include discussing client diagnosis in a public elevator, disclosing lab results to an inquiring friend without authorization, and leaving an unattended open EHR at the nurses' station, whereas handoffs to assigned oncoming nurses, mandated communicable disease reporting, and identity-verified calls with approved contacts are permitted.
- **Keyed Rule A (ZH):** 侵犯隐私（保密）的行为包括在公共电梯讨论诊断、未经授权向询问的朋友透露化验结果以及在护士站让打开的电子病历无人看管；而向接班负责护士交接、法定传染病上报以及与经核实身份的获批联系人沟通均属合规。
- **Keyed Rule B (EN):** In a disclosure log review, disclosing protected health information (substance abuse treatment) to a client's neighbor in a waiting room is an unauthorized disclosure and a HIPAA breach, whereas sending records through a client-requested secure portal, verifying two identifiers on telephone calls, and releasing transfer records to an authorized facility for continuity of care are permitted disclosures.
- **Keyed Rule B (ZH):** 在信息披露记录审核中，向候诊区患者的邻居透露受保护健康信息（戒断治疗）属于未经授权披露和HIPAA违规；而按患者要求通过安全门户发送、电话中核对两个身份识别信息以及向转院机构提供交接资料均属合规披露。
- **Strongest Real Reconciliation:** Both items apply identical federal HIPAA Privacy Rule standards: disclosing PHI to unauthorized third parties (friends, neighbors, or public bystanders) or leaving PHI unsecured constitutes a breach, whereas sharing PHI for direct treatment, care continuity, mandated reporting, or patient-authorized portals is fully compliant.
- **Reconciliation Test:** Both items reinforce consistent privacy boundaries regarding who possesses a legitimate 'need to know' vs unauthorized third parties.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Flawless HIPAA privacy alignment across multiple clinical disclosure scenarios.

### Pair 31 (Part A #31)
- **Item A ID:** `claude_moc_hipaa_breach_hl_b03`
- **Item B ID:** `gpt_deepen_2026_06_22_moc_11`
- **Shared Clinical Decision:** Recognition of proper vs improper information transmission and privacy safeguards for protected health information.
- **Keyed Rule A (EN):** Confidentiality is breached when protected health information is improperly exposed in public areas, shared with unauthorized friends, or left unattended on computer terminals.
- **Keyed Rule A (ZH):** 当受保护健康信息在公共场所暴露、向未获授权的朋友透露或在电脑终端无人看管时，构成隐私违规。
- **Keyed Rule B (EN):** Faxing protected health information to an unverified old number creates a high risk of unauthorized disclosure to the wrong recipient and represents a breach requiring privacy follow-up, whereas disclosures under a signed release, treatment-related provider sharing, and secure transfer systems are permitted.
- **Keyed Rule B (ZH):** 将受保护健康信息传真至未经核实的旧号码会产生向错误接收者泄露的高风险，属于需要隐私跟进处理的违规行为；而经签署授权的披露、治疗相关的医务人员共享以及安全转送系统均属允许范围。
- **Strongest Real Reconciliation:** Item A addresses physical/verbal privacy safeguards at the bedside and nurses' station, while Item B addresses facsimile and electronic data transmission safeguards. Both enforce the strict HIPAA mandate that PHI must only be transmitted to verified, authorized recipients.
- **Reconciliation Test:** Physical confidentiality protocols (Item A) and electronic/fax transmission verification protocols (Item B) represent harmonious applications of HIPAA privacy standards.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Coherent application of HIPAA privacy standards across verbal, physical, and electronic communication channels.

### Pair 32 (Part B #1)
- **Item A ID:** `cs_ckd_01_q3`
- **Item B ID:** `gemini_jun05_a_sata_pacemaker_41`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Arteriovenous (AV) fistula and renal diet discharge teaching for chronic kidney disease / hemodialysis includes: avoiding constricting clothing, blood pressure cuffs, or heavy bags on the access arm; daily palpation/auscultation for thrill and bruit; taking phosphate binders with meals; and restricting high-potassium foods (e.g. leafy greens).
- **Keyed Rule A (ZH):** 慢性肾脏病/血液透析患者动静脉瘘（AV瘘）及饮食出院指导包括：避免在造瘘侧肢体测血压、穿紧身衣或提重物；每日触诊震颤并听诊杂音；随餐服用磷结合剂；以及限制高钾食物（如绿叶蔬菜）。
- **Keyed Rule B (EN):** Permanent cardiac pacemaker post-implantation discharge instructions include: avoiding shoulder extension / arm lifting above shoulder level on the operative side initially to prevent lead dislodgement; carrying a pacemaker identification card; checking daily pulse; avoiding prolonged close proximity to anti-theft security systems; and recognizing that MRI requires device-specific clearance rather than being unconditionally safe.
- **Keyed Rule B (ZH):** 永久性心脏起搏器植入术后出院指导包括：术后早期避免术侧手臂抬高过肩以防电极脱位；随身携带起搏器识别卡；每日监测脉搏；避免在防盗门禁系统附近长时间停留；并明确MRI需要特定设备许可而非无条件安全。
- **Strongest Real Reconciliation:** Item A provides vascular access and metabolic dietary instructions for a chronic hemodialysis client, while Item B provides surgical precautions and electromagnetic interference guidelines for a cardiac electrophysiology pacemaker recipient.
- **Reconciliation Test:** The two items involve completely separate organ systems, device types, and patient populations; no shared decision or conflicting rule exists.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; completely unrelated clinical domains (hemodialysis AV fistula vs cardiac pacemaker discharge education).

### Pair 33 (Part B #2)
- **Item A ID:** `cs_ckd_01_q3`
- **Item B ID:** `trad_batchD_08`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Hemodialysis AV fistula care requires avoiding pressure on the fistula extremity and monitoring patency, while renal diet requires phosphate binders with meals and potassium restriction.
- **Keyed Rule A (ZH):** 血液透析AV瘘护理要求避免在造瘘侧受压并监测通畅性，肾病饮食要求随餐服用磷结合剂并限制钾。
- **Keyed Rule B (EN):** Clinical assessment of early compensatory shock includes identifying tachycardia (compensatory mechanism to preserve cardiac output), cool/clammy skin (peripheral vasoconstriction), tachypnea, oliguria, and a narrowing pulse pressure.
- **Keyed Rule B (ZH):** 早期代偿性休克的临床评估表现包括心动过速（维持心输出量的代偿机制）、皮肤湿冷（外周血管收缩）、呼吸急促、尿量减少以及脉压变窄。
- **Strongest Real Reconciliation:** Item A addresses chronic outpatient vascular access maintenance and renal diet, while Item B addresses acute critical care hemodynamic cues of compensatory shock.
- **Reconciliation Test:** Completely distinct clinical specialties and patient acuity levels; zero shared decision space.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; chronic dialysis self-care vs acute compensatory shock assessment.

### Pair 34 (Part B #3)
- **Item A ID:** `cs_ckd_01_q3`
- **Item B ID:** `trad_batchD_10`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Hemodialysis AV fistula care requires avoiding BP cuffs/blood draws on the access arm and checking thrill/bruit, alongside taking phosphate binders with meals.
- **Keyed Rule A (ZH):** 血液透析AV瘘护理要求造瘘臂禁测血压/抽血并检查震颤与杂音，配合随餐服用磷结合剂。
- **Keyed Rule B (EN):** Prevention of central line-associated bloodstream infections (CLABSI/CRBSI) for a central venous catheter (CVC) requires strict hand hygiene, scrubbing the access hub with antiseptic for 15+ seconds before entry, using maximal sterile barrier precautions for dressing changes, changing transparent dressings every 7 days (or when soiled), and avoiding topical antibiotic ointments.
- **Keyed Rule B (ZH):** 预防中心静脉导管（CVC）相关血流感染（CLABSI/CRBSI）要求严格手卫生、每次接管前用力消毒擦拭接头15秒以上、换药时使用最大无菌屏障、透明敷料每7天（或污染时）更换，并避免使用局部抗生素软膏。
- **Strongest Real Reconciliation:** Item A addresses peripheral arteriovenous fistula physical protection and renal diet, while Item B addresses central venous vascular access catheter bundle maintenance and aseptic hub scrubbing.
- **Reconciliation Test:** Peripheral AV fistula preservation principles and central venous catheter infection prevention bundles operate in separate procedural domains without contradiction.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; peripheral hemodialysis fistula care vs central venous catheter CLABSI prevention.

### Pair 35 (Part B #4)
- **Item A ID:** `cs_ckd_01_q3`
- **Item B ID:** `trad_batchD_20`
- **Shared Clinical Decision:** Clinical assessment, dietary regulation, and nursing management of fluid volume status in clients with impaired fluid regulation.
- **Keyed Rule A (EN):** Clients with chronic kidney disease / end-stage renal disease must adhere to dietary/fluid management (restricting sodium/potassium, taking phosphate binders with meals) and protect vascular access to prevent interdialytic fluid overload and uremic complications.
- **Keyed Rule A (ZH):** 慢性肾衰竭/终末期肾病患者必须坚持饮食与体液管理（限制钠/钾、随餐服磷结合剂）并保护血管通路，以防透析期间体液过负荷及尿毒症并发症。
- **Keyed Rule B (EN):** Fluid volume excess (hypervolemia) produces objective signs of elevated intravascular volume and central venous congestion, including jugular venous distension (JVD), bounding peripheral pulses, elevated central venous pressure (CVP), pulmonary crackles, and peripheral edema.
- **Keyed Rule B (ZH):** 体液容量过多（高血容量）产生血管内容量增加和静脉淤血的客观体征，包括颈静脉怒张（JVD）、洪脉、中心静脉压（CVP）升高、肺部湿啰音及外周水肿。
- **Strongest Real Reconciliation:** Item A provides outpatient self-care and dietary education to prevent fluid volume overload in renal disease, while Item B delineates the clinical assessment findings that signify active fluid volume excess.
- **Reconciliation Test:** Preventative dietary/access teaching and physical assessment markers of hypervolemia are fully concordant components of fluid balance nursing.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; complementary connection between renal fluid management education and hypervolemia clinical manifestations.

### Pair 36 (Part B #5)
- **Item A ID:** `cs_ckd_01_q3`
- **Item B ID:** `trad_batchD_24`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Hemodialysis AV fistula care involves protecting the arm from constricting pressure and assessing patency, combined with phosphate binders and dietary potassium limits.
- **Keyed Rule A (ZH):** 血液透析AV瘘护理涉及防止造瘘侧受压并评估通畅度，结合磷结合剂与限钾饮食。
- **Keyed Rule B (EN):** Clinical manifestations of an acute hemolytic transfusion reaction include low back/flank pain (due to hemoglobin precipitation in renal tubules), fever, chills, tachycardia, hypotension, and apprehension (whereas JVD indicates circulatory overload TACO, not acute hemolysis).
- **Keyed Rule B (ZH):** 急性溶血性输血反应的临床表现包括腰背痛（血红蛋白在肾小管沉淀所致）、发热、寒战、心动过速、低血压及恐惧感（而JVD提示输血相关循环超负荷TACO，非急性溶血）。
- **Strongest Real Reconciliation:** Item A addresses chronic hemodialysis access care and diet, while Item B addresses acute immunologic transfusion reactions during blood product administration.
- **Reconciliation Test:** Different clinical scenarios with no shared decision pathway or conflicting rules.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; chronic dialysis teaching vs acute hemolytic blood transfusion reaction.

### Pair 37 (Part B #6)
- **Item A ID:** `cs_ckd_01_q5`
- **Item B ID:** `gemini_c8_08`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** In evaluating the outcome of a hemodialysis session, reaching the client's prescribed target 'dry weight' is the most reliable indicator of effective ultrafiltration fluid removal.
- **Keyed Rule A (ZH):** 在评估血液透析疗效时，达到预设的“干体重”是反映超滤脱水有效最可靠的指标。
- **Keyed Rule B (EN):** Following a thoracentesis, the acute development of asymmetrical chest expansion and tracheal deviation indicates a life-threatening tension pneumothorax requiring immediate emergency needle decompression.
- **Keyed Rule B (ZH):** 胸腔穿刺术后，急性出现的胸廓不对称扩张及气管移位提示危及生命的张力性气胸，需立即行紧急针头减压。
- **Strongest Real Reconciliation:** Item A evaluates ultrafiltration efficacy following routine hemodialysis, while Item B evaluates post-thoracentesis tension pneumothorax emergency recognition.
- **Reconciliation Test:** No common decision or rule tension exists between hemodialysis weight metrics and thoracentesis procedural complications.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; hemodialysis dry weight metric vs post-thoracentesis tension pneumothorax.

### Pair 38 (Part B #7)
- **Item A ID:** `claude_a_sata_tracheostomy_09`
- **Item B ID:** `cs_ckd_01_q3`
- **Shared Clinical Decision:** NONE
- **Keyed Rule A (EN):** Appropriate actions during tracheostomy care include: maintaining sterile technique, pre-suctioning the airway prior to care, using pre-cut split drain sponges around the stoma (never cutting standard gauze to avoid fiber aspiration), and rinsing the reusable inner cannula with sterile saline after cleaning.
- **Keyed Rule A (ZH):** 气管切开护理中的正确措施包括：保持无菌技术、护理前预先吸痰以清理气道、造口周围使用预切开叉纱布（切勿自行剪开普通纱布防纤维吸入），以及清洗后用无菌生理盐水冲洗内套管。
- **Keyed Rule B (EN):** Hemodialysis AV fistula care requires protecting the access arm from constricting pressure and palpating for a thrill, combined with phosphate binders taken with meals.
- **Keyed Rule B (ZH):** 血透AV瘘护理要求保护造瘘侧肢体免受压迫并触诊震颤，配合随餐服用磷结合剂。
- **Strongest Real Reconciliation:** Item A teaches airway and tracheostomy aseptic stoma care, while Item B teaches vascular access protection and renal dietary compliance.
- **Reconciliation Test:** Independent procedural and physiological domains with no shared clinical decision.
- **Verdict:** `NO_SHARED_DECISION` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (claude×mixed); tracheostomy care vs hemodialysis fistula teaching.

### Pair 39 (Part B #8)
- **Item A ID:** `cs_stemi_vfib_04_part_1`
- **Item B ID:** `gemini_b1_04`
- **Shared Clinical Decision:** Clinical assessment, electrocardiographic localization, and hemodynamic monitoring of acute myocardial infarction based on anatomical coronary artery territory.
- **Keyed Rule A (EN):** Acute anterior wall STEMI (left anterior descending coronary artery occlusion) presents with ST elevation in precordial leads V1-V4, crushing substernal chest pain radiating to the jaw, and profound sympathetic nervous system activation (diaphoresis, resting tachycardia HR 110).
- **Keyed Rule A (ZH):** 急性前壁STEMI（左前降支闭塞）表现为胸前导联V1-V4的ST段抬高、向颌部放射的压榨样胸痛以及显著的交感神经激活（大汗、静息心动过速HR 110次/分）。
- **Keyed Rule B (EN):** Acute inferior wall STEMI (right coronary artery occlusion) frequently involves the SA and AV nodal blood supply, predisposing the client to parasympathetic/vagal hyperactivity (nausea/vomiting), sinus bradycardia, Type I AV block (Wenckebach), and concurrent right ventricular infarction.
- **Keyed Rule B (ZH):** 急性下壁STEMI（右冠状动脉闭塞）常累及窦房结和房室结血供，使患者易发生副交感/迷走神经兴奋（恶心/呕吐）、窦性心动过缓、I度/II度I型房室传导阻滞以及合并右室心肌梗死。
- **Strongest Real Reconciliation:** The clinical presentations differ according to coronary vascular anatomy: Anterior STEMI (Item A, LAD) affects left ventricular anterior myocardium and triggers intense sympathetic hyperstimulation (tachycardia, diaphoresis), whereas Inferior STEMI (Item B, RCA) involves conduction nodes and inferior/diaphragmatic wall, eliciting vagal stimulation and bradyarrhythmias.
- **Reconciliation Test:** These represent classic, standard cardiovascular pathophysiology distinctions between anterior and inferior infarct territories with zero clinical contradiction.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; accurate anatomical distinction between anterior STEMI (sympathetic activation/tachycardia) and inferior STEMI (vagal/bradycardia/AV block).

### Pair 40 (Part B #9)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01`
- **Item B ID:** `gpt_gap_2026_06_12_nonmcq_balanced_case_pressure_injury_nutrition_03`
- **Shared Clinical Decision:** Comprehensive nursing assessment, anatomical staging, preventative offloading, and nutritional optimization for pressure injury management in high-risk clients.
- **Keyed Rule A (EN):** Pressure injury management across an unfolding case requires: staging based on anatomical tissue depth (Stage 1 intact nonblanchable, Stage 2 partial-thickness dermis, Stage 3 full-thickness into subcutaneous fat, Stage 4 exposed bone/muscle, unstageable when obscured by slough/eschar); preventative interventions including q2h repositioning, heel floating, pressure-redistribution surfaces, prompt moisture care, and strict avoidance of massaging reddened bony prominences; and anabolic nutritional support (high protein, calories, vitamin C, zinc).
- **Keyed Rule A (ZH):** 压力性损伤综合管理要求：依据解剖组织深度分期（1期完整红斑不苍白、2期真皮部分缺损、3期全层延伸至皮下脂肪、4期骨肌外露、基底被腐肉/焦痂遮盖为不可分期）；预防措施包括至少每2小时翻身、足跟悬空、使用减压支撑垫、及时处理潮湿、严禁按摩发红骨突处；以及营养支持（高蛋白、高热量、维生素C、锌）。
- **Keyed Rule B (EN):** Pressure injury prevention and wound healing in a vulnerable client requires connecting clinical risk cues (immobility, urinary/fecal incontinence, malnutrition) to individualized repositioning schedules, heel offloading/floating, moisture barrier application, and dietary consultation to ensure adequate protein and caloric intake.
- **Keyed Rule B (ZH):** 高危患者压力性损伤预防与伤口愈合要求结合临床风险线索（活动受限、大小便失禁、营养不良），实施个体化翻身摆位、足跟悬空减压、使用皮肤屏障霜，并请营养师会诊确保充足蛋白质和热量摄入。
- **Strongest Real Reconciliation:** Both unfolding case studies adhere strictly to NPIAP clinical practice guidelines: implementing scheduled repositioning, floating heels, avoiding massage of bony prominences, protecting skin from moisture, and prioritizing high-protein nutrition for tissue repair.
- **Reconciliation Test:** The clinical staging definitions, preventive nursing interventions, and nutritional healing strategies are completely identical and harmonious.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (mixed×gpt); comprehensive pressure injury case study alignment.

### Pair 41 (Part B #10)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01_part_2`
- **Item B ID:** `gpt_canonical_matrix_pressure_injury_040`
- **Shared Clinical Decision:** Core nursing interventions and safety precautions in pressure injury prevention for bedbound clients.
- **Keyed Rule A (EN):** Interventions in the plan of care to prevent further pressure injury include: repositioning at least every 2 hours, floating heels off the bed with a pillow under calves, using a pressure-redistribution support surface, and managing moisture/incontinence promptly, while vigorously massaging reddened areas and maintaining head of bed above 45 degrees are contraindicated.
- **Keyed Rule A (ZH):** 预防压力性损伤加重的护理计划措施包括：至少每2小时翻身一次、小腿垫枕使足跟悬空、使用减压支撑面、及时处理失禁潮湿；而用力按摩发红区域及持续将床头抬高45度以上均属禁忌。
- **Keyed Rule B (EN):** Helpful interventions for pressure injury prevention include repositioning at least every 2 hours, keeping the head of bed at or below 30 degrees (to minimize sacral shear and friction), and using moisture barriers; unsafe actions include massaging reddened bony prominences (causes deep tissue ischemia) and using donut-shaped ring cushions (impairs surrounding venous return).
- **Keyed Rule B (ZH):** 预防压力性损伤的有益措施包括至少每2小时翻身、床头抬高<=30度（以减少骶尾部剪切力和摩擦力）、使用皮肤屏障；不安全行为包括按摩发红骨突处（引起深部组织缺血）和使用甜甜圈形环形坐垫（阻碍周围静脉回流）。
- **Strongest Real Reconciliation:** Both items teach identical evidence-based prevention rules: turn at least q2h, offload heels, keep head of bed low (<=30°) to prevent shear, maintain dry skin, and strictly avoid both massage of reddened bony prominences and donut cushions.
- **Reconciliation Test:** The safe vs unsafe intervention classifications are completely concordant across both items.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (mixed×gpt); identical pressure injury prevention and safety rules.

### Pair 42 (Part B #11)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01_part_4`
- **Item B ID:** `gemini_d8_10`
- **Shared Clinical Decision:** Clinical staging, anatomical classification, and documentation of pressure injuries based on tissue layer involvement.
- **Keyed Rule A (EN):** A pressure injury on a heel covered by thick, black, nonviable eschar that completely obscures visualization of the wound base depth must be documented and classified as an Unstageable pressure injury until debridement permits visualization of true depth.
- **Keyed Rule A (ZH):** 足跟处覆盖有厚层黑色坏死焦痂且完全遮盖创面基底深度的压力性损伤，必须记录并归类为不可分期（Unstageable）压力性损伤，直至清创后能观察到真实深度。
- **Keyed Rule B (EN):** A pressure injury in the sacral area that is 2 cm deep with visible subcutaneous fat and slough, but without exposed muscle, tendon, or bone, is classified and documented as a Stage 3 pressure injury.
- **Keyed Rule B (ZH):** 骶尾部深2厘米、可见皮下脂肪和腐肉但未暴露肌肉、肌腱或骨骼的创面，应记录并归类为3期（Stage 3）压力性损伤。
- **Strongest Real Reconciliation:** The two items apply standard NPIAP anatomical staging criteria to two distinct wound presentations: Item A presents an injury whose base is fully obscured by necrotic eschar (defining an unstageable injury), while Item B presents full-thickness loss extending into subcutaneous tissue with visible fat and slough but intact fascia/muscle/bone (defining Stage 3).
- **Reconciliation Test:** Both items accurately operationalize NPIAP staging definitions; there is zero conflict between unstageable criteria and Stage 3 criteria.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; standard NPIAP staging application (unstageable eschar vs Stage 3 subcutaneous fat).

### Pair 43 (Part B #12)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01_part_4`
- **Item B ID:** `opus_bcc_rehab_2026_06_10_01`
- **Shared Clinical Decision:** Pressure injury risk factor assessment (Braden Scale) and wound stage documentation in rehabilitation care.
- **Keyed Rule A (EN):** When a pressure injury base is obscured by necrotic eschar so depth cannot be visualized, the wound is documented as unstageable.
- **Keyed Rule A (ZH):** 当压力性损伤创面基底被坏死焦痂遮盖以致无法观察深度时，创面应记录为不可分期。
- **Keyed Rule B (EN):** In a post-stroke rehabilitation client, hemiplegia (severe mobility/activity limitation), urinary incontinence (moisture/maceration), poor oral intake of 50% (nutritional deficit), lack of discomfort on bony prominences (impaired sensory perception), and advanced age (tissue fragility) all represent significant risk factors that increase pressure injury risk on the Braden Scale.
- **Keyed Rule B (ZH):** 在脑卒中康复患者中，偏瘫（活动能力严重受限）、尿失禁（潮湿/浸渍）、饮食仅摄入50%（营养不足）、骨突受压无不适感（感觉感知受损）及高龄（组织脆弱）在Braden评分中均属于显著增加压力性损伤发生风险的危险因素。
- **Strongest Real Reconciliation:** Item A evaluates wound classification criteria for established deep tissue necrosis (unstageable), while Item B evaluates multi-factorial risk prediction using the Braden Scale (sensory perception, moisture, activity, mobility, nutrition).
- **Reconciliation Test:** Risk assessment (Item B) and wound staging (Item A) represent complementary phases of pressure injury clinical practice.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (mixed×gpt); Braden Scale risk factor assessment vs unstageable wound staging.

### Pair 44 (Part B #13)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01`
- **Item B ID:** `gpt_case_gap_2026_06_11_case_pressure_injury_ltc_04`
- **Shared Clinical Decision:** Multimodal pressure injury management, clinical staging, preventative offloading, and interprofessional nutrition care in long-term care.
- **Keyed Rule A (EN):** Pressure injury care requires precise anatomical staging, routine offloading (heel floating, q2h turns, pressure-redistribution surfaces), prompt moisture management, avoidance of massage on reddened skin, and anabolic nutritional support (protein/zinc/vitamin C).
- **Keyed Rule A (ZH):** 压力性损伤护理需要精准解剖分期、常规减压（足跟悬空、每2小时翻身、减压支撑垫）、及时潮湿管理、严禁按摩发红皮肤以及营养支持（蛋白质/锌/维生素C）。
- **Keyed Rule B (EN):** Long-term care pressure injury prevention requires recognizing sensory/mobility/nutritional risk cues, establishing an individualized repositioning schedule, floating heels, applying barrier creams for incontinence, requesting pressure-redistribution mattresses, consulting a dietitian for protein/calorie supplementation, and maintaining appropriate RN assessment/delegation boundaries.
- **Keyed Rule B (ZH):** 长期照护中的压力性损伤预防要求识别感觉/活动/营养风险线索、制定个体化翻身计划、足跟悬空、使用失禁屏障霜、申请减压床垫、请营养师指导蛋白质/热量补充，并维持正确的RN评估与任务委派界限。
- **Strongest Real Reconciliation:** Both comprehensive case studies enforce identical evidence-based prevention and treatment bundles: individualized repositioning, heel floating, skin barrier application, pressure-redistribution support surfaces, and high-protein nutrition consultation.
- **Reconciliation Test:** The clinical rules, safety constraints (e.g. no massage of reddened areas), and interdisciplinary nutrition pathways match completely across both cases.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (mixed×gpt); complete harmony across comprehensive pressure injury unfolding cases.

### Pair 45 (Part B #14)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01`
- **Item B ID:** `gpt_case_premium_2026_06_10_case04_pressure_injury_rehab`
- **Shared Clinical Decision:** Interdisciplinary pressure injury prevention, seating mechanics, and client self-care education in rehabilitation settings.
- **Keyed Rule A (EN):** Pressure injury care integrates tissue-depth staging, frequent repositioning, heel offloading, pressure-redistribution support surfaces, and nutritional optimization.
- **Keyed Rule A (ZH):** 压力性损伤护理整合了组织深度分期、频繁翻身、足跟减压、压力再分布支撑垫以及营养优化。
- **Keyed Rule B (EN):** In rehabilitation pressure injury prevention, wheelchair seating requires pressure-redistribution cushions while strictly prohibiting donut/ring cushions (which concentrate pressure and cause venous congestion); heels must be floated with offloading boots/pillows; skin over bony prominences must be inspected at least daily; and clients with sensory loss must be taught that absence of pain does not mean absence of tissue injury.
- **Keyed Rule B (ZH):** 在康复科压力性损伤预防中，轮椅摆位需使用压力再分布坐垫并严格禁用甜甜圈环形坐垫（后者集中压力并导致静脉淤血）；必须用减压靴/枕头使足跟悬空；骨突处皮肤每日至少检查一次；并教育感觉减退患者“无疼痛感不代表无组织损伤”。
- **Strongest Real Reconciliation:** Both case studies enforce consistent pressure-relief standards: replacing ring/donut cushions with proper pressure-redistributing surfaces, offloading heels, avoiding tissue massage, and educating patients with impaired sensation.
- **Reconciliation Test:** The rehabilitation seating rules and prevention principles in Item B directly complement and expand upon the core wound care principles in Item A.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (mixed×gpt); fully concordant pressure injury prevention and wheelchair seating protocols.

### Pair 46 (Part B #15)
- **Item A ID:** `claude_cs_jun06_pressure_injury_bcc_01_part_2`
- **Item B ID:** `gpt_case_gap_2026_06_11_pressure_ltc_part_2_sata_plan`
- **Shared Clinical Decision:** Core evidence-based nursing interventions for pressure injury prevention care planning.
- **Keyed Rule A (EN):** The prevention plan must include repositioning at least every 2 hours, floating heels using a pillow under calves, utilizing a pressure-redistribution support surface, and managing moisture/incontinence promptly, while vigorously massaging reddened areas and keeping head of bed >45 degrees are avoided.
- **Keyed Rule A (ZH):** 预防计划必须包括至少每2小时翻身一次、小腿垫枕使足跟悬空、使用压力再分布支撑面以及及时处理潮湿/失禁；同时避免用力按摩发红区域及床头抬高>45度。
- **Keyed Rule B (EN):** The long-term care prevention plan must include establishing an individualized repositioning schedule, offloading heels off the mattress, providing prompt incontinence care and barrier cream, requesting evaluation for a pressure-redistribution surface, and consulting a dietitian for protein/calorie needs, while massaging reddened bony prominences is contraindicated.
- **Keyed Rule B (ZH):** 长期照护预防计划必须包括制定个体化重新摆位计划、使足跟离开床垫减压、及时失禁护理并使用屏障霜、申请评估减压支撑面以及因蛋白质/热量需求咨询营养师；同时禁忌按摩发红骨突处。
- **Strongest Real Reconciliation:** Both SATA items teach identical core prevention standards: scheduled repositioning, heel offloading, prompt incontinence care with barrier creams, pressure-redistribution surfaces, and dietary protein support, while explicitly identifying massage over reddened bony areas as harmful tissue trauma.
- **Reconciliation Test:** The two items are entirely aligned in both their included (safe) and excluded (unsafe) interventions.
- **Verdict:** `RECONCILABLE` | **Confidence:** `HIGH` | **Source Check Needed:** `False`
- **Notes:** Part B advisory pair; clean review (mixed×gpt); identical evidence-based pressure injury prevention care plan items.
